Design a Coordinated Nano-Platform for Coumarin-Regulated Delivery in Line with the Biological Systems’ Growth Phases

Abstract

A full-control design can significantly improve drug release and cell proliferation for tissue engineering applications in medicine. The present investigation encompassed a molecular docking study which was performed to investigate the interaction of selected active ligand (coumarin) with the L929 mouse fibroblast cell line protein as the receptor. After that, the coumarin was extracted from the roots of p.ferulacea and its subsequent nanoencapsulation with polycaprolactone, employing the coacervation technique to achieve a narrow distribution of nano particle sizes. Subsequently, the electrospinning technique was utilized to apply a second coating to the nano-encapsulated coumarin. Polyvinyl alcohol and gelatin compounds were used to produce electrospun nanofibrous scaffolds for their similarity to the extracellular matrix (ECM). This coordinated nano platform aimed to assess its effectiveness in regulating drug release, evaluate its biocompatibility, and examine its impact on L929 cell proliferation according to the Lag and Log phases of their growth. In silico analyses demonstrated significant interactions and high binding energy values between the coumarin ligand and essential residues of the L929 mouse fibroblast proteins. The results of the experiments were checked using analyses of ¹H NMR, FTIR, UV, SEM, mechanical properties, DSC, HRTEM, and HPLC. The biological effects and cell proliferation were conducted employing the MTT method (up to 5 days). Notably, no cytotoxicity was detected throughout the assessment. In this way, it is feasible to create a synergistic nano delivery system by delaying the release of the drug into account the timing of distinct cell lines’ development phases.